- ►ahajournals.org J Kim, M Montagnani, KK Koh, MJ Quon - Circulation, 2006 - Am Heart Assoc Endothelial dysfunction contributes to cardiovascular diseases, including
hypertension, atherosclerosis, and coronary artery disease, which are also
characterized by insulin resistance. Insulin resistance is a hallmark of ... Cited by 322 - Related articles - All 9 versions
- ►onlinejacc.org KK Koh, SH Han, MJ Quon - Journal of the American College of Cardiology, 2005 - Elsevier Inflammation in the vasculature might be an important pathogenic link between
cardiovascular diseases and the metabolic syndrome. Inflammation can be reduced
by a variety of approaches including diet, exercise, cardiovascular drugs, ... Cited by 119 - Related articles - BL Direct - All 16 versions
- ►endojournals.org R Muniyappa, M Montagnani, KK Koh, MJ … - Endocrine reviews, 2007 - Endocrine Soc Insulin has important vascular actions to stimulate production of nitric oxide
from endothelium. This leads to capillary recruitment, vasodilation, increased
blood flow, and subsequent augmentation of glucose disposal in classical ... Cited by 101 - Related articles - BL Direct - All 5 versions
- ►onlinejacc.org S Kinlay - Journal of the American College of Cardiology, 2007 - Elsevier This study sought to assess the contribution of low-density lipoprotein
(LDL)–dependent and LDL–independent effects of LDL-lowering therapies to
changes in C-reactive protein (CRP) in healthy or stable subjects. Cited by 60 - Related articles - BL Direct - All 17 versions
P Libby, J Plutzky - The American Journal of Cardiology, 2007 - Elsevier Patients with type 2 diabetes mellitus and/or the metabolic syndrome have
considerable cardiovascular risk. Treatment with 3-hydroxy-3-methylglutaryl
coenzyme A reductase inhibitors (statins) and with antihypertensive and ... Cited by 60 - Related articles - All 32 versions
C Savoia, E Schiffrin - Clinical Science, 2007 - submit.clinsci.org Abbreviations: ACE, angiotensin-converting enzyme; Ang II, angiotensin II; ARB,
angiotensin receptor blocker; AT 1 , Ang II type 1; BMI, body mass index; BP,
blood pressure; COX-2, cyclo-oxygenase-2; CRP, C-reactive protein; ET, ... Cited by 55 - Related articles - Cached - BL Direct - All 9 versions
K ALEXANDRAKI, C PIPERI, C KALOFOUTIS, … - Annals of the New York Academy of Sciences, 2006 - ingentaconnect.com Population-based studies have shown strong relationship between inflammatory
markers and metabolic disturbances, obesity, and atherosclerosis, whereas
inflammation has been considered as a “common soil” between these ... Cited by 51 - Related articles - BL Direct - All 4 versions
- ►physiology.org H Chen, RJ Karne, G Hall, U Campia, JA … - American Journal of Physiology- Heart and Circulatory …, 2006 - Am Physiological Soc Endothelial dysfunction is a hallmark of Type 2 diabetes related to
hyperglycemia and oxidative stress. Nitric oxide-dependent vasodilator actions
of insulin may augment glucose disposal. Thus endothelial dysfunction may ... Cited by 44 - Related articles - BL Direct - All 4 versions
- ►ahajournals.org SH Han, MJ Quon, KK Koh - Hypertension, 2005 - Am Heart Assoc Fibric acid is a synthetic ligand of the nuclear receptor peroxisome
proliferator-activated receptor (PPAR)- that is highly expressed in skeletal
muscle and heart, where it promotes ß-oxidation of fatty acids to mediate ... Cited by 43 - Related articles - All 8 versions
- ►ahajournals.org A Hiuge, A Tenenbaum, N Maeda, M Benderly, … - Arteriosclerosis, thrombosis, and vascular biology, 2007 - Am Heart Assoc From Department of Metabolic Medicine (AH, NM, MK, TH, KF, HN, SK, IS, TF),
Graduate School of Medicine, Osaka University, Osaka, Japan; Cardiac
Rehabilitation Institute (AT, EZF, YA, MM), The Israel Society for the ... Cited by 39 - Related articles - All 8 versions
